#VisualAbstract: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved....
#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Click to read the study in NEJM ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Microaxial Flow Pumps Reduces Mortality But Increases Adverse Events Compared to Standard Care For Cardiogenic Shock
Click to read the study in The New England Journal of Medicine ©2024 2 Minute Medicine, Inc. All rights reserved....
#VisualAbstract: Alectinib Improves Disease-Free Survival in ALK-Positive Non-Small-Cell Lung Cancer Compared to Platinum-Based Chemotherapy
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
#VisualAbstract: FFR-Guided Complete Percutaneous Coronary Intervention Is Non-Superior to Culprit-Only Percutaneous Coronary Intervention
Click to read the study in The New England Journal of Medicine ©2024 2 Minute Medicine, Inc. All rights reserved....
#VisualAbstract: RSV Prefusion F Protein-Based Maternal Vaccine Lowers Risk of Infant RSV Infection but Increases the Risk of Preterm Birth
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
#VisualAbstract: Enfortumab Vedotin and Pembrolizumab Reduces Mortality in Metastatic Urothelial Carcinoma
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved....
#VisualAbstract: Benralizumab is noninferior to mepolizumab for treatment of eosinophilic granulomatosis with polyangitis
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
#VisualAbstract: Tenecteplase therapy initiated within 4.5 to 24 hours after stroke symptom onset is non-superior to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without...
#VisualAbstract: Acoramidis is an efficacious treatment for transthyretin amyloid cardiomyopathy compared to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without...